These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
94 related articles for article (PubMed ID: 11134397)
1. Adeno-associated virus in normal and myositis human skeletal muscle. Tezak Z; Nagaraju K; Plotz P; Hoffman EP Neurology; 2000 Dec; 55(12):1913-7. PubMed ID: 11134397 [TBL] [Abstract][Full Text] [Related]
2. Focal myositis: a clinicopathologic study of 115 cases of an intramuscular mass-like reactive process. Auerbach A; Fanburg-Smith JC; Wang G; Rushing EJ Am J Surg Pathol; 2009 Jul; 33(7):1016-24. PubMed ID: 19363438 [TBL] [Abstract][Full Text] [Related]
3. Directed evolution of adeno-associated virus (AAV) as vector for muscle gene therapy. Yang L; Li J; Xiao X Methods Mol Biol; 2011; 709():127-39. PubMed ID: 21194025 [TBL] [Abstract][Full Text] [Related]
4. Herpes simplex virus type 1/adeno-associated virus hybrid vectors mediate site-specific integration at the adeno-associated virus preintegration site, AAVS1, on human chromosome 19. Heister T; Heid I; Ackermann M; Fraefel C J Virol; 2002 Jul; 76(14):7163-73. PubMed ID: 12072516 [TBL] [Abstract][Full Text] [Related]
12. Characterization of adeno-associated virus genomes isolated from human tissues. Schnepp BC; Jensen RL; Chen CL; Johnson PR; Clark KR J Virol; 2005 Dec; 79(23):14793-803. PubMed ID: 16282479 [TBL] [Abstract][Full Text] [Related]
13. Triple trans-splicing adeno-associated virus vectors capable of transferring the coding sequence for full-length dystrophin protein into dystrophic mice. Koo T; Popplewell L; Athanasopoulos T; Dickson G Hum Gene Ther; 2014 Feb; 25(2):98-108. PubMed ID: 24191945 [TBL] [Abstract][Full Text] [Related]
14. Genetic counselling in myopathies of childhood. Tygstrup I; Plum P Acta Obstet Gynecol Scand Suppl; 1974; 29():65-7. PubMed ID: 4526167 [No Abstract] [Full Text] [Related]
15. Dual AAV Gene Therapy for Duchenne Muscular Dystrophy with a 7-kb Mini-Dystrophin Gene in the Canine Model. Kodippili K; Hakim CH; Pan X; Yang HT; Yue Y; Zhang Y; Shin JH; Yang NN; Duan D Hum Gene Ther; 2018 Mar; 29(3):299-311. PubMed ID: 28793798 [TBL] [Abstract][Full Text] [Related]
16. [Gene therapy for muscular dystrophy]. Takeda S No To Hattatsu; 2004 Mar; 36(2):117-23. PubMed ID: 15031985 [TBL] [Abstract][Full Text] [Related]
17. Inflammatory response in facioscapulohumeral muscular dystrophy (FSHD): immunocytochemical and genetic analyses. Arahata K; Ishihara T; Fukunaga H; Orimo S; Lee JH; Goto K; Nonaka I Muscle Nerve Suppl; 1995; 2():S56-66. PubMed ID: 7739627 [TBL] [Abstract][Full Text] [Related]
18. Detection of adeno-associated virus type 2 genome in cervical carcinoma. Zheng BY; Li XD; Wiklund F; Chowdhry S; Angstrom T; Hallmans G; Dillner J; Wallin KL Br J Cancer; 2006 Jun; 94(12):1913-7. PubMed ID: 16736006 [TBL] [Abstract][Full Text] [Related]
19. Focal myositis of the neck. Ho KL; Konno ET; Chason JL Hum Pathol; 1979 May; 10(3):353-6. PubMed ID: 468219 [TBL] [Abstract][Full Text] [Related]